Light, examination, mobile Australien - Englisch - Department of Health (Therapeutic Goods Administration)

light, examination, mobile

tacmed australia pty ltd - 36843 - light, examination, mobile - a portable light source used in a mobile hospital or surgical facility.

Gauze roll, sterile Australien - Englisch - Department of Health (Therapeutic Goods Administration)

gauze roll, sterile

tacmed australia pty ltd - 48127 - gauze roll, sterile - a sterile device designed to be a primary wound dressing on a patient?s body. this is a single use device.

Adhesive bandage Australien - Englisch - Department of Health (Therapeutic Goods Administration)

adhesive bandage

tacmed australia pty ltd - 34864 - adhesive bandage - to create an occlusive seal around penetrating injuries

Pleural catheter Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pleural catheter

tacmed australia pty ltd - 37482 - pleural catheter - a sterile needle designed to be inserted through an intercostal space and into the pleural cavity (potential space between the serous membranes covering the lungs) to establish a channel for the removal of air causing a pneumothorax to permit full expansion of the lungs. this is a single-use device.

ORALAIR Continuation Treatment Sublingual (Allergen pollen Extract of 5 grasses) Tablets 300IR blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

oralair continuation treatment sublingual (allergen pollen extract of 5 grasses) tablets 300ir blister pack

stallergenes australia pty ltd - poa pratensis, quantity: 20 %; anthoxanthum odoratum, quantity: 20 %; phleum pratense, quantity: 20 %; dactylis glomerata, quantity: 20 %; lolium perenne, quantity: 20 % - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.

ORALAIR Initiation Treatment, Sublingual (Allergen pollen Extract of 5 grasses) Tablets 100IR & 300IR Blister Pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

oralair initiation treatment, sublingual (allergen pollen extract of 5 grasses) tablets 100ir & 300ir blister pack

stallergenes australia pty ltd - lolium perenne, quantity: 20 %; phleum pratense, quantity: 20 %; anthoxanthum odoratum, quantity: 20 %; dactylis glomerata, quantity: 20 %; poa pratensis, quantity: 20 % - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; lactose monohydrate - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.

Actair 100 IR & 300 IR Initiation treatment sublingual tablets Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

actair 100 ir & 300 ir initiation treatment sublingual tablets

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 50 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)); dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) - sublingual tablet - 100ir & 300ir - active: dermatophagoides farinae allergen extract 50 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

Actair 300 IR Continuation treatment sublingual tablets Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

actair 300 ir continuation treatment sublingual tablets

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) - sublingual tablet - 300 ir - active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

ECO2FUME.. Neuseeland - Englisch - Ministry for Primary Industries

eco2fume..

cytec australia holdings pty ltd - phosphine - phosphine 20 g/kg - insecticide